| Author/Editor | Knap, Bojan | |
| Title | Kardiorenalna anemija - problem in zdravljenje | |
| Translated title | Cardiorenal anemia - problem and treatment | |
| Type | članek | |
| Source | Med Razgl | |
| Vol. and No. | Letnik 42, št. Suppl 4 | |
| Publication year | 2003 | |
| Volume | str. 63-4 | |
| Language | slo | |
| Abstract | The connection between the cardiovascular system and kidneys in regulating the volume and composition of bodily fluids surpasses the current fragmentation of patient management to various internal medicine specialities. Therefore, multiorgan impairment in the elderly requires an integration of knowledge in the various specialities of internal medicine. In cardiorenal anemia, the expertise of a hematologist, cardiologist and nephrologist intertwine. Newer possibilities for early treatment with erythropoietin ensure better results of treatment in patients with secondary anemia resulting from initial global renal insufficiency and concurrent renal hypoperfusion due to heart failure. When and to what extent should one treat secondary anemia? The target hemoglobin values in the treatment of anemia with erythropoietin in chronic renal insufficiency are close to those on the lower limit of the normal range, reducing stress on the heart and enabling better cognitive functioning. | |
| Summary | Povezava srčno-žilnega sistema in ledvic pri kontroli volumna in sestave telesnih tekočin presega razdrobljenost obravnavanja bolnikov s strani različnih specialistov interne medicine, zato več-organska prizadetost starejših bolnikov zahteva integracijo znanja s področja interne medicine različnih specialnosti. Pri kardiorenalni anemiji se prepletajo delovanja hematologa, kardiologa in nefrologa. Novejše možnosti zgodnjega zdravljenja z eritropoetinom zagotavljajo boljše rezultate zdravljenja pri bolnikih s sekundarno anemijo, ki je posledica začetnega ledvičnega popuščanja in istočasne nezadostne prekrvavitve ledvic zaradi srčnega popuščanja. Kdaj in v kolikšni meri zdraviti sekundarno anemijo? Vrednosti ciljnega hemoglobina se pri zdravljenju anemije z eritropoetinom pri kroničnem ledvičnem popuščanju približujejo vrednostim na spodnji meji normale in omogočajo manjšo obremenitev srca ter boljše kognitivne funkcije. | |
| Descriptors | HEART FAILURE, CONGESTIVE KIDNEY FAILURE ANEMIA ERYTHROPOIETIN AGED |